Exercise of Options

RNS Number : 2038F
Allergy Therapeutics PLC
20 April 2011
 



20 April 2011

 

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

 

Exercise of Options

 

 

Allergy Therapeutics plc (AIM: AGY), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, announces it has made an application to the London Stock Exchange for 15,000 ordinary shares of 0.1p each to be admitted to trading on AIM. Dealing is expected to commence in these shares on 21 April 2011. The ordinary shares have been allotted pursuant to the exercise of options and will rank pari passu in all respects with the existing ordinary share capital of the Company. The total number of shares in issue (inclusive of the above issue) is 310,771,614 ordinary shares of 0.1p each.

 

 

 

For further information

 

Allergy Therapeutics

+44 (0) 1903 845 820

Manuel Llobet, Chief Executive Officer


Ian Postlethwaite, Finance Director


www.allergytherapeutics.com




Nomura Code Securities

+44 (0) 207 776 1200

Juliet Thompson/ Clare Terlouw




Financial Dynamics

+44 (0) 207 831 3113

Ben Brewerton/ Susan Quigley


 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISEALLNFSNFEFF
UK 100

Latest directors dealings